Skip to content

Pyronaridine

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: malaridine, pyronaridine tetraphosphate

ATC P01BF06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pyronaridine is a drug catalogued in DrugCentral. Recorded indications include Falciparum malaria and Vivax malaria.

  • Indications: Falciparum malaria and Vivax malaria.
  • ATC code: P01BF06 (Artemisinin and derivatives, combinations).
  • Molecular formula: C29H32ClN5O2; molecular weight 518.06 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Falciparum malaria
  • Vivax malaria

ATC classification

ATC codeTherapeutic hierarchy
P01BF06ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations

Chemical structure

Molecular formulaC29H32ClN5O2
Molecular weight518.06 g/mol
CAS number74847-35-1
InChIKeyDJUFPMUQJKWIJB-UHFFFAOYSA-N
PubChem CID107771
COC1=CC=C2N=C3C=C(Cl)C=CC3=C(NC3=CC(CN4CCCC4)=C(O)C(CN4CCCC4)=C3)C2=N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pyronaridine used for?

DrugCentral lists the following indications for Pyronaridine: Falciparum malaria and Vivax malaria.

What is the chemical formula of Pyronaridine?

Pyronaridine has the molecular formula C29H32ClN5O2 and a molecular weight of 518.06 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications2
FormulaC29H32ClN5O2
DrugCentral ID4339
Interactive profile